4Cairo M S, Bishop M. Tumor lysis syndrome: new therapeutic strategies and classification[J]. Br J Haematol,2001,127(1):3- 11.
5Otrock Z K, Hatoum H A, Salem Z M. et al. Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma [J]. Intern Emerg Med.2008.3(2):161-163.
6Fleming D R. Doukas M A. Acute lumor lysis syndrome in hematologic malignancies [J]. Leuk Lymphoma. 1992,8(4-5): 315-318.
7Cohen I. F, Balow J E. Magrath I T, et al. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma[J]. Am J Med,1980,68(4):486-491.
8Hande K R, Garrow G C. Acute lumor lysis syndrome in patients with high grade non Hodgkin's lymphoma[J]. Am J Med, 1993, 94(2) : 133-139.
9Locatelli F, Rossi F. Incidence and pathogenesis of tumor lysis syndrome[J]. Contrib Nephrol,2005,147:61-68.
10McLaughlin P, Grillo-Lopez A J, Link B K, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four dose treatment program[J]. J Clin Oncol,1998.16(8):2825-2833.
